These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


526 related items for PubMed ID: 6402387

  • 1. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY, Wrixon W, Zayid I, Acorn T, Popat R, Wilson E.
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [Abstract] [Full Text] [Related]

  • 2. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
    Ling WY, Wrixon W, Acorn T, Wilson E, Collins J.
    Fertil Steril; 1983 Nov; 40(5):631-6. PubMed ID: 6628707
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate.
    Toddyvalla V, Johannisson E, Landgren BM, Cekan SZ, Diczfalusy E.
    Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759
    [Abstract] [Full Text] [Related]

  • 4. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 5. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Jul; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL, Katz M.
    Contraception; 1979 Nov 15; 20(5):475-87. PubMed ID: 393456
    [Abstract] [Full Text] [Related]

  • 11. Mode of action of DL-norgestrel and ethinylestradiol combination in postcoital contraception.
    Ling WY, Robichaud A, Zayid I, Wrixon W, MacLeod SC.
    Fertil Steril; 1979 Sep 15; 32(3):297-302. PubMed ID: 488410
    [Abstract] [Full Text] [Related]

  • 12. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
    Johansson ED, Elamsson K, Elmestedt U.
    Gynecol Obstet Invest; 1982 Sep 15; 14(2):97-105. PubMed ID: 6811379
    [No Abstract] [Full Text] [Related]

  • 13. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS, Chapdelaine A, Upmalis D, Olson W, Smith J.
    Acta Obstet Gynecol Scand Suppl; 1992 Sep 15; 156():9-14. PubMed ID: 1324557
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE, Kettel LM, Yen SS.
    Fertil Steril; 1992 Aug 15; 58(2):338-43. PubMed ID: 1633899
    [Abstract] [Full Text] [Related]

  • 16. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
    Landgren BM, Johannisson E, Aedo AR, Kumar A, Shi YE.
    Contraception; 1989 Mar 15; 39(3):275-89. PubMed ID: 2496951
    [Abstract] [Full Text] [Related]

  • 17. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
    Kuhl H, Gahn G, Romberg G, März W, Taubert HD.
    Contraception; 1985 Jun 15; 31(6):583-93. PubMed ID: 2931247
    [Abstract] [Full Text] [Related]

  • 18. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent.
    Yuzpe AA, Smith RP, Rademaker AW.
    Fertil Steril; 1982 Apr 15; 37(4):508-13. PubMed ID: 7040117
    [Abstract] [Full Text] [Related]

  • 19. A comparison of high-dose estrogens versus low-dose ethinylestradiol and norgestrel combination in postcoital interception: a study in 493 women.
    Van Santen MR, Haspels AA.
    Fertil Steril; 1985 Feb 15; 43(2):206-13. PubMed ID: 3881294
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.